Safety of an HIV DNA Vaccine Given to HIV Uninfected Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

Not specified

Study Completion Date

April 30, 2003

Conditions
HIV Infections
Interventions
BIOLOGICAL

pGA2/JS2 Plasmid DNA Vaccine

Trial Locations (4)

94102

UCSF, Gen. Clinical Research Ctr., Mt. Zion Hosp., San Francisco

Unknown

Alabama Vaccine CRS, Birmingham

San Francisco Vaccine and Prevention CRS, San Francisco

FHCRC/UW Vaccine CRS, Seattle

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH